Plasma Transcriptome Profile Associated with Chronic Kidney Disease Progression
Warranting further validation, circulating levels of aberrantly expressed transcripts hold potential to be used as biomarkers for fast CKD progression.
Authors
- Dominic S. Raj (ORCID: https://orcid.org/0000-0001-9647-083X)
- Michael Gombert
- Divya Shankaranarayanan (ORCID: https://orcid.org/0009-0006-8028-9618)
- Jeffrey B. Kopp (ORCID: https://orcid.org/0000-0001-9052-186X)
- Richard Amdur (ORCID: https://orcid.org/0000-0002-4900-653X)
- Yoosif Abdalla
- Mark Maienschein‐Cline
- Katalin Suszták (ORCID: https://orcid.org/0000-0002-1005-3726)
- Ana Pabalan
- Haiming Cao
- Anvesha Srivastava
Institutions
- National Institutes of Health (US)
- Northwell Health (US)
- Feinstein Institute for Medical Research (US)
- George Washington University (US)
- University of Illinois Chicago (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- National Heart, Lung, and Blood Institute (US)
- Qiagen (Germany) (DE)
- University of Pennsylvania (US)
Publication Details
- Journal
- American Journal of Nephrology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1159/000542707
- Primary Topic
- Renal and related cancers
- Type
- article
- Field-Weighted Citation Impact
- 0.00